Outset Medical adds former Stryker leader as new EVP of commercial
Outset Medical has appointed Derick Elliott, formerly of Stryker and Cardinal Health, as its new Executive Vice President of Commercial. Effective immediately, Elliott will oversee the company's commercial organizations supporting acute, post-acute, and home healthcare providers. His extensive experience in medtech sales and marketing, including his previous role as CCO at SpendMed, aligns with Outset Medical's strategy for its portable hemodialysis system, Tablo.
Stryker’s global manufacturing network now “fully operational” following cyberattack
Stryker has announced that its global manufacturing network is fully operational again after a cyberattack disrupted its operations. The company stated that production is rapidly moving towards peak capacity with strong product supply across most lines, assuring customers and partners that patient care remains the highest priority. Stryker also clarified that the incident was not ransomware, was contained, and did not compromise product safety or customer data, though some personalized implant cases were rescheduled due to shipping delays.
Fulton Breakefield Broenniman LLC Acquires 14,641 Shares of Stryker Corporation $SYK
Fulton Breakefield Broenniman LLC increased its stake in Stryker Corporation by 41.3%, purchasing 14,641 additional shares and bringing its total holdings to 50,123 shares valued at $17.617 million. This makes Stryker its 25th-largest position. Despite a director selling 250,000 shares for $90.73 million, institutional investors still own 77.09% of the company.
Surgical Robotics Market to Reach US$15.25 Billion by 2033
The global surgical robotics market is projected to grow from US$5.84 billion in 2024 to US$15.25 billion by 2033, exhibiting an 11.3% CAGR, driven by increased adoption of robotic-assisted systems for enhanced precision and patient outcomes. North America currently leads the market with a 51% share due to advanced healthcare infrastructure and strong presence of key players, while major drivers include demand for minimally invasive surgeries, rising chronic disease prevalence, and technological advancements like AI integration. Key players in this evolving market include Intuitive Surgical, Stryker Corporation, and CMR Surgical.
Outset Medical names Derick Elliott commercial chief By Investing.com
Outset Medical, Inc. (NASDAQ:OM) has appointed Derick Elliott as Executive Vice President of Commercial, effective immediately. Elliott brings over 30 years of sales and marketing experience from Stryker, Cardinal Health, and SpendMend, and will be responsible for overseeing the company's commercial organizations. The company's stock has seen an 11% gain in the past week, and InvestingPro analysis suggests it may be undervalued.
Stryker Corporation (SYK) stock price, news, quote and history
This article provides comprehensive financial information for Stryker Corporation (SYK), a medical technology company. It includes real-time stock data, historical performance, key financial metrics, earnings trends, and analyst insights. The company operates globally in medical devices, specializing in MedSurg, Neurotechnology, and Orthopaedics segments.
Hologic CEO Steve MacMillan to retire after go-private deal
Hologic CEO Steve MacMillan will retire following the company's acquisition by Blackstone and TPG for $18.3 billion. The deal is set to close on Tuesday after receiving all necessary regulatory approvals. MacMillan led Hologic for 13 years, significantly increasing revenue and share price, and will be succeeded by a new CEO named upon the acquisition's completion.
Hologic CEO Steve MacMillan to Retire After Private Equity Deal
Hologic CEO Steve MacMillan has announced his retirement following the impending closure of the $18.3 billion go-private transaction with Blackstone and TPG. During his 12-plus years, Hologic's revenue grew 65% and its share price increased 241%. The transaction is expected to close on or about April 7, 2026, with a new CEO to be announced afterward.
Hologic CEO Steve MacMillan To Retire
Hologic, Inc. announced that CEO Steve MacMillan will retire following the company's go-private transaction with Blackstone and TPG, expected to close around April 7, 2026. MacMillan's 12-plus year tenure saw significant growth in revenue, earnings per share, and stock price, along with the company's response to the COVID pandemic. The board and MacMillan expressed gratitude for his leadership, and a new CEO is expected to be announced upon the transaction's close.
Rathbones Group PLC Has $77.07 Million Position in Stryker Corporation $SYK
Rathbones Group PLC significantly increased its stake in Stryker Corporation (NYSE:SYK) by 647.9% in the last quarter of the previous year, now holding shares valued at $77.07 million. This move comes as Stryker reported strong fourth-quarter earnings, beating analyst estimates, and maintains a "Moderate Buy" rating from analysts with an average price target of $427.50. Despite director Ronda E. Stryker selling a substantial block of shares, institutional investors collectively own 77.09% of the company.
Quilter Plc Has $33.13 Million Stock Position in Stryker Corporation $SYK
Quilter Plc recently reduced its stake in Stryker Corporation (NYSE:SYK) by 3.8% in Q4, holding 94,248 shares valued at $33.13 million. Despite this, other hedge funds significantly increased their positions, with institutional investors owning 77.09% of the company. Analysts have a "Moderate Buy" rating for Stryker, with a consensus price target of $427.50.
Runnymede Capital Advisors Inc. Takes $3.25 Million Position in Stryker Corporation $SYK
Runnymede Capital Advisors Inc. recently acquired a new position in Stryker Corporation (NYSE:SYK), purchasing 9,255 shares valued at approximately $3.25 million, making it their 15th largest holding. Analysts currently rate Stryker as a "Moderate Buy" with an average price target of $427.50, despite some mixed adjustments from various firms. The medical technology company recently exceeded quarterly earnings estimates and declared a $0.88 quarterly dividend, while a director sold a significant number of shares.
Orthopaedics Market Set to Boom Rapidly by 2033 | Smith & Nephew • DePuy Synthes • NuVasive
Coherent Market Insights has released a comprehensive report titled "Orthopaedics Market: Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2026-2033," predicting rapid growth in the orthopaedics sector. The report analyzes market competition, geographic distribution, and growth potential, covering industry performance, success factors, and economic analysis. It serves as a vital tool for entrepreneurs, investors, and business strategists, highlighting major market players like Johnson & Johnson, Stryker Corporation, and Zimmer Biomet.
Cooke Wealth Management LLC Takes Position in Stryker Corporation $SYK
Cooke Wealth Management LLC has acquired a new position in Stryker Corporation (NYSE:SYK), purchasing 13,200 shares valued at approximately $4.74 million, making it their 10th largest holding. This comes as Stryker's director, Ronda E. Stryker, recently sold 250,000 shares for $90.73 million, reducing her stake by 9.23%. The medical technology company reported strong quarterly earnings, beating analyst estimates with $4.47 EPS and $7.17 billion in revenue, and maintains a "Moderate Buy" consensus rating from analysts with an average price target of $427.50.
Florida Trust Wealth Management Co Raises Holdings in Stryker Corporation $SYK
Florida Trust Wealth Management Co increased its stake in Stryker Corporation (NYSE:SYK) by 6.0% in the fourth quarter, bringing its total holdings to 57,858 shares valued at $20.335 million. This comes after Stryker reported strong quarterly earnings of $4.47 EPS, beating estimates, and revenue of $7.17 billion, an 11.4% year-over-year increase. Despite a director's recent sale of 250,000 shares, analysts maintain a "Moderate Buy" rating for the medical technology company with a consensus price target of $427.50.
Stryker's First Quarter Report: A Crucial Test for Growth Strategy
Stryker's Q1 2026 earnings report on April 30th will be a critical test for the company's growth strategy, especially concerning its surgical robotics performance and orthopaedic innovations, as its stock has recently faced significant pressure. Investors and analysts will be closely watching the initial performance of the Mako Robotic Power System and other strategic product launches to assess whether these investments can drive operational recovery. The report comes amidst a share price decline and a new VP of Investor Relations appointment, highlighting the company's transitional phase.
Stryker's First Quarter Report: A Crucial Test for Growth Strategy
Stryker's upcoming Q1 2026 results on April 30 will be a crucial test for its growth strategy, especially after recent stock pressure and a 12% decline over 30 days. Investors are keenly focused on the performance of the Mako Robotic Power System and other orthopaedic innovations. The report will assess if strategic investments in robotics and specialized implants are driving operational recovery.
Value Stock Risks: Analyst Concerns on 3 Companies in 2026 - News and Statistics
StockStory's analysis highlights three value stocks—Zimmer Biomet, Renasant, and Eastern Bankshares—as potentially risky investments for 2026 due to concerns over future performance despite current valuations. Zimmer Biomet faces issues with below-peer revenue growth and low returns on capital. Renasant shows slow revenue growth and declining earnings per share, while Eastern Bankshares struggles with credit quality and low return on equity.
Quintet Private Bank Europe S.A. Sells 3,934 Shares of Stryker Corporation $SYK
Quintet Private Bank Europe S.A. reduced its stake in Stryker Corporation by 58.4% in the fourth quarter, selling 3,934 shares and ending with 2,808 shares worth $987,000. Additionally, Director Ronda E. Stryker sold 250,000 shares for $90.73 million, representing a 9.23% reduction in her holdings. Stryker reported strong quarterly earnings, beating analyst estimates and maintaining a consensus "Moderate Buy" rating with a $427.50 price target, alongside declaring a $0.88 quarterly dividend.
Aberdeen Group plc Sells 12,821 Shares of Stryker Corporation $SYK
Aberdeen Group plc reduced its stake in Stryker Corporation by 4.2% in the fourth quarter, selling 12,821 shares, though still holding 295,845 shares valued at over $103 million. Concurrently, Stryker Director Ronda E. Stryker sold 250,000 shares for $90.73 million, decreasing her position by 9.23%. Stryker reported strong quarterly earnings, beating estimates with $4.47 EPS and $7.17 billion in revenue, and declared a quarterly dividend of $0.88 per share.
Stryker says it has recovered from cyberattack
Medical products company Stryker Corp. announced on April 1 that it has fully recovered from a cyberattack that affected its manufacturing network for three weeks. The attack, attributed to the Iran-sponsored hacking group Hamsa, disrupted commercial, ordering, and distribution systems. Stryker has confirmed the incident was contained to its networks, did not affect its medical products or patient data, and is continuing its investigation with cybersecurity experts and government officials.
Stryker Outperforms IM Cannabis in Medical Technology Comparison
An analysis comparing medical technology companies Stryker (NYSE:SYK) and IM Cannabis (NASDAQ:IMCC) concludes that Stryker is the more favorable investment. Stryker demonstrates stronger financials, less stock volatility, and a better consensus rating from analysts, outperforming IM Cannabis on 12 out of 14 comparative factors. This makes Stryker a more attractive option for investors seeking stability and potential growth in the medical technology sector.
Zimmer Biomet Holdings, Inc. (ZBH) stock price, news, quote and history
This page provides a comprehensive overview of Zimmer Biomet Holdings, Inc. (ZBH) stock, including real-time quotes, historical data, company profile, and financial analysis. It details the company's performance metrics, recent news, analyst ratings, and compares it with similar medical device companies. The content also highlights key financial figures and upcoming earnings dates for ZBH investors.
Does Stryker’s Cyberattack Recovery Reveal Hidden Strengths in Its Long-Term Thesis (SYK)?
Stryker (SYK) experienced a cyberattack in March 2026, which temporarily impacted custom implant operations. However, the company rapidly restored its electronic ordering system and most manufacturing capacity. This quick recovery is prompting investors to evaluate Stryker's resilience and its long-term investment thesis, especially ahead of its Q1 2026 earnings report due on April 30.
Stryker back online after cyberattack | brief | SC Media
Medical device company Stryker has fully resumed operations three weeks after a cyberattack by the Iran-linked hacktivist group Handala. The attack involved wiping systems and allegedly stealing 50 TB of data, but Stryker has announced that manufacturing, ordering, and distribution are back to normal with strong product availability. The investigation continues with third-party experts and government agencies, identifying a malicious file used by the attackers.
Stryker Fully Operational After March Cyberattack
Stryker has announced that it is fully operational again after a cyberattack on March 11, with systems restored and production capacity ramping up. The attack, attributed to the Iran-linked group Handala, involved wiping nearly 80,000 Windows devices and exfiltrating 50 terabytes of data. While operations were temporarily disrupted and some surgical procedures delayed, the company confirmed no impact on product safety or security, and it is now facing at least six lawsuits from employees due to stolen personal data.
Stryker Corporation (SYK) stock price, news, quote and history
This page provides a comprehensive overview of Stryker Corporation (SYK), a medical technology company. It includes current stock performance, historical data, financial metrics, and analyst insights. The company operates in MedSurg & Neurotechnology and Orthopaedics segments, offering a wide range of medical devices.
Cyberattack fallout hits Stryker with lawsuits over worker data
Stryker is facing legal action due to a cyberattack that exposed employee data. The company headquarters are located in Portage, and the incident has led to multiple lawsuits. The article was published on April 3, 2026.
Medical device giant Stryker is back online three weeks after data-wiping cyberattack
Stryker Corporation, a leading medical technology company, has fully recovered and is operational across its global manufacturing network three weeks after a data-wiping cyberattack. The attack, claimed by the hacktivist group Handala, involved wiping tens of thousands of systems and servers and extracting 50 terabytes of data. Stryker, a Fortune 500 company with $25.1 billion in revenue in 2025, has restored all systems and is working with cybersecurity experts and government agencies to investigate the incident.
Medtech giant Stryker says it’s back up after Iranian cyberattack
Medtech company Stryker has announced it is fully operational again, three weeks after an Iranian cyberattack by the Handala group. The attack on March 11 impacted order processing, manufacturing, and shipping, but production is now rapidly returning to peak capacity. Stryker is continuing its investigation and recovery efforts with cybersecurity experts and government agencies, maintaining that patient care remains its top priority.
Medtech giant Stryker fully operational after data-wiping attack
Medical technology company Stryker announced it is fully operational three weeks after a data-wiping cyberattack by the Iranian-linked Handala hacktivist group. The company restored systems to pre-attack operational levels and production is rapidly returning to full capacity. The FBI also seized two websites used by the Handala hackers, who are known for targeting Israeli organizations and have been linked to Iran's Ministry of Intelligence and Security.
Bank Pictet & Cie Europe AG Buys 11,943 Shares of Stryker Corporation $SYK
Bank Pictet & Cie Europe AG increased its stake in Stryker Corporation by 8.2% in the fourth quarter, acquiring an additional 11,943 shares, bringing its total holdings to 157,040 shares valued at approximately $55.2 million. This makes Stryker its 25th largest position, accounting for about 1.1% of its portfolio. Simultaneously, Stryker Director Ronda E. Stryker sold 250,000 shares for $90.73 million, reducing her stake by 9.23%, though corporate insiders still own 5.90% of the company.
SYK SEC Filings - Stryker Corp 10-K, 10-Q, 8-K Forms
This page on Stock Titan provides comprehensive access to Stryker Corporation's (NYSE: SYK) SEC filings, including 10-K annual reports, 10-Q quarterly reports, 8-K material event reports, and insider trading forms. It highlights how these documents offer insights into Stryker's financial condition, governance, and key events as a global medical technologies company. The platform also uses AI-powered tools to summarize key points from these filings, helping investors quickly understand important disclosures.
Medical device giant consolidates Memphis operations
Stryker, a medical device maker, is consolidating its Memphis operations by moving from a leased East Memphis facility to its owned Arlington facility. This move will be implemented through a phased approach. The Memphis Business Journal reported on this development.
World Arthroscopy Devices - Market Analysis, Forecast, Size, Trends and Insights
The global arthroscopy devices market is expected to grow at a 6.2% CAGR from 2026 to 2035, driven by an aging population, rising sports injuries, and technological advancements. The market is shifting from capital equipment to consumables, with knee and shoulder arthroscopy being the largest segments. North America currently holds the largest market share, while Asia-Pacific is projected for the fastest growth.
Michigan's Stryker: Manufacturing network now 'fully operational' after cyberattack
Stryker's global manufacturing network is now fully operational after a cyberattack in March, with production moving towards peak capacity and a healthy product supply. The company is continuing its investigation with cybersecurity experts and government agencies, while facing multiple lawsuits alleging insufficient protection of sensitive personal information. The cyberattack was linked to an Iranian hacking group, which used a malicious file that did not spread or target external parties.
Stryker says operations a fully restored after March cyberattack
International healthcare product manufacturer Stryker announced that its operations are fully restored three weeks after a cyberattack disrupted its network on March 11. Production facilities are returning to peak capacity, and most product lines have healthy stock levels. The cyberattack, which was tied to Iran's Ministry of Intelligence and Security, affected several communication methods for employees and led some health systems to temporarily stop using Stryker products.
Michigan's Stryker: Manufacturing network now 'fully operational' after cyberattack
Stryker, a Michigan-based medical technologies leader, has announced its global manufacturing network is now fully operational following a cyberattack in March. Production is moving towards peak capacity with restored systems and overall product supply remains healthy. The company confirmed a "threat actor" used a malicious file and is continuing its investigation with cybersecurity experts, while also facing multiple lawsuits alleging failure to protect sensitive personal information.
Michigan's Stryker: Manufacturing network now 'fully operational' after cyberattack
Stryker's global manufacturing network is now fully operational following a cyberattack in March. The company stated that production is moving toward peak capacity, and overall product supply remains healthy. Stryker is continuing its investigation into the incident with cybersecurity experts and government agencies, while several lawsuits have been filed against the company alleging failure to protect sensitive personal information.
Stryker names Nick Mead Vice President, Investor Relations
Stryker has appointed Nick Mead as Vice President, Investor Relations, effective May 1, 2026. Mead brings nearly 20 years of experience within Stryker, having held various leadership roles across multiple divisions. Concurrently, Jason Beach, the former VP, Finance and Investor Relations, has been named Vice President, Group Chief Financial Officer, MedSurg and Neurotechnology.
Every Minute Counts at Kirkland’s Kestra Medical Technologies
Kestra Medical Technologies, based in Kirkland, is saving lives with its wearable cardioverter defibrillator, the Assure system. The device has protected over 300 individuals from sudden cardiac arrest since 2021, and the company is now focusing on expanding its market reach following positive results from a four-year study. Kestra emphasizes its mission-driven culture and strives for diversity, aiming to protect a larger portion of the 850,000 U.S. patients at risk annually.
Stryker’s Sustainability Solutions division Single-Use Medical Devices Reprocessing Program Helps Reforest Willamette National Forest
Stryker's Sustainability Solutions division is partnering with the National Forest Foundation to reforest parts of the Willamette National Forest in Oregon. This initiative is part of Stryker's "Products for the Planet" program, which uses proceeds from reprocessing single-use medical devices to plant trees in National Forests. The 2021 planting will focus on restoring areas affected by the 2020 Beachie Creek, Holiday Farm, and Lionshead Fires, contributing over 41,000 mixed conifer seedlings to improve watershed health and visual quality.
Stryker to announce financial results for its first quarter of fiscal year 2026
Stryker (NYSE: SYK) will report its first-quarter fiscal year 2026 financial results on Thursday, April 30, 2026. A press release will be issued around 4:05 p.m. ET, followed by a webcast at 4:30 p.m. ET to discuss the results. The financial information will cover the quarter ending March 31, 2026.
Stryker to release March-quarter results after market on April 30
Stryker (NYSE:SYK) has announced it will release its first-quarter fiscal year 2026 financial results on April 30, 2026. A press release detailing the summary financial information for the quarter ended March 31, 2026, will be issued at approximately 4:05 p.m. ET, followed by a live webcast at 4:30 p.m. ET. Historically, similar earnings date announcements from Stryker have resulted in only modest stock price movements.
Moody Lynn & Lieberson LLC Has $29.52 Million Stock Position in Stryker Corporation $SYK
Moody Lynn & Lieberson LLC reduced its stake in Stryker Corporation (NYSE:SYK) by 6.8% in the fourth quarter, now owning 83,991 shares valued at $29.52 million. Other institutional investors like Vanguard Group Inc., State Street Corp, and Alliancebernstein L.P. increased their holdings. Stryker recently announced a quarterly dividend of $0.88, payable on April 30th to shareholders of record on March 31st.
Capital Advisors Inc. OK Purchases 8,229 Shares of Stryker Corporation $SYK
Capital Advisors Inc. OK increased its stake in Stryker Corporation by 5.0% in Q4 2025, acquiring an additional 8,229 shares, bringing their total to 172,517 shares valued at $60.64 million. Concurrently, Director Ronda E. Stryker sold 250,000 shares for $90.73 million in February, reducing her position by 9.23%. Stryker reported strong quarterly earnings, beating analyst estimates, and maintains a "Moderate Buy" consensus rating with a $427.50 target price and offers an 1.1% dividend yield.
Inked: Stryker, AutoZone and Scan Global Logistics making local moves
This article covers recent commercial real estate activities in the greater Memphis area, highlighting moves by major companies. Stryker Corp., a medical equipment manufacturer, has confirmed its relocation from East Memphis offices. The full details of this and other transactions by AutoZone and Scan Global Logistics are available to subscribers.
Stryker names Nick Mead Vice President, Investor Relations
Stryker has appointed Nick Mead as Vice President, Investor Relations, effective May 1, 2026. Mead brings 20 years of experience within Stryker, having held various leadership roles in finance across multiple divisions. Concurrently, Jason Beach, the former Vice President, Finance and Investor Relations, has been named Vice President, Group Chief Financial Officer, MedSurg and Neurotechnology.
OrthoPediatrics Corp Stock: Specialized Pediatric Orthopedics Leader Faces Sector Headwinds and Grow
OrthoPediatrics Corp (NASDAQ: KIDS) is highlighted as a leader in specialized pediatric orthopedic solutions, serving a niche market distinct from larger competitors. The company's business model involves direct sales of implants and devices for trauma, deformity, spine, and sports medicine in children, supported by ongoing R&D and strategic acquisitions. While benefiting from high barriers to entry and strong clinical evidence, investors should consider risks such as reimbursement changes, sales force dependence, and competitive pressures.
Trends in Growth, Segment Analysis, and Competitive Approaches
The hand-held surgical instruments market is projected to reach $12.96 billion by 2030, growing at an 11.5% CAGR, driven by advanced surgical techniques, infection prevention, and outpatient surgeries. Key players include Johnson & Johnson, B. Braun Melsungen AG, and Zimmer Biomet Holdings Inc., with significant innovation seen in precision tools and ergonomic designs. Recent acquisitions, such as STERIS PLC's purchase of Becton, Dickinson and Company's surgical assets, are shaping the competitive landscape.
